Literature DB >> 28849387

Evaluation of tablet punch configuration on mitigating capping by a quality by design approach.

Parind M Desai1,2, Parthiban Anbalagan1, Cheryl J N Koh1, Paul W S Heng1, Celine V Liew3.   

Abstract

Capping is a common problem in the manufacture of some types of tablets and unless resolved, the tableting process cannot proceed. Hence, all factors that can help to lessen the likelihood of capping without unnecessarily reduce turret speed and/or compaction force would be tenable. This study investigated the influence of tablet punch configuration on mitigation of tablet capping. Tablets were prepared from high-dose paracetamol-potato starch granules in a rotary tablet press with flat face plain (FFP), flat face bevel edge (FFBE) and flat face radius edge (FFRE) punch configurations. The directly compressible (DC) fillers tested were microcrystalline cellulose (MCC), pre-gelatinised starch (PGS) and lactose. Design of experiments (DoE), a tool of quality by design (QbD) paradigm, was used and the interaction of input variables (compression force, tablet punch configuration and DC filler) affecting the response factors (tablet hardness and capping rating) were evaluated. FFP punches were able to mitigate capping best. FFRE punches showed more potential than FFBE punches at alleviating capping in a particular compression force range, without the limitations of the FFP punches that produce cylindrical tablets that were more friable. Incorporation of PGS in the tablet formulation was observed to be more efficient at mitigating capping than the other DC fillers when FFBE and FFRE punches were used. Overall, this study serves as a model for prospective product development based on the QbD framework and the optimal use of compaction tools.

Entities:  

Keywords:  Capping; Design of experiments; Formulation; Punch configuration; Quality by design; Tablets

Mesh:

Substances:

Year:  2018        PMID: 28849387     DOI: 10.1007/s13346-017-0425-0

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  8 in total

1.  Effect of compression speeds on the compaction properties of a 1:1 paracetamol-microcrystalline cellulose mixture prepared by single compression and by combinations of pre-compression and main-compression.

Authors: 
Journal:  Int J Pharm       Date:  1997-11-28       Impact factor: 5.875

2.  Quality by design approach for formulation development: a case study of dispersible tablets.

Authors:  Naseem A Charoo; Areeg A A Shamsher; Ahmed S Zidan; Ziyaur Rahman
Journal:  Int J Pharm       Date:  2011-12-23       Impact factor: 5.875

3.  Quality by design approach to understand the process of nanosuspension preparation.

Authors:  Sudhir Verma; Yan Lan; Rajeev Gokhale; Diane J Burgess
Journal:  Int J Pharm       Date:  2009-05-14       Impact factor: 5.875

4.  Influence of rate of force application during compression on tablet capping.

Authors:  Srimanta Sarkar; Shing Ming Ooi; Celine Valeria Liew; Paul Wan Sia Heng
Journal:  J Pharm Sci       Date:  2015-01-07       Impact factor: 3.534

5.  Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach.

Authors:  Parind Mahendrakumar Desai; Patrick Xuan Hua Er; Celine Valeria Liew; Paul Wan Sia Heng
Journal:  AAPS PharmSciTech       Date:  2014-05-22       Impact factor: 3.246

6.  Quantitative correlation of the effect of process conditions on the capping tendencies of tablet formulations.

Authors:  Ilgaz Akseli; Adrian Stecuła; Xiaorong He; Nadia Ladyzhynsky
Journal:  J Pharm Sci       Date:  2014-03-25       Impact factor: 3.534

Review 7.  Review of Disintegrants and the Disintegration Phenomena.

Authors:  Parind Mahendrakumar Desai; Celine Valeria Liew; Paul Wan Sia Heng
Journal:  J Pharm Sci       Date:  2016-02-12       Impact factor: 3.534

8.  Radial and axial tensile strength and strength variability of paracetamol tablets.

Authors:  G Alderborn; C Nyström
Journal:  Acta Pharm Suec       Date:  1984
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.